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Euclea natalensis A. DC. belonging to the family Ebenaceae, is widely used for curing bronchitis, pleurisy, chronic asthma and urinary tract
infections by the Zulus, in South Africa. Four triterpenes namely lupeol, betulin, β-sitosterol, 20(29)-lupene-3β-isoferulate and two naphthoquinones
shinanolone and octahydroeuclein isolated from the ethanolic extract of E. natalensis root bark were investigated for their antifungal activity against
Aspergillus flavus, Aspergillus niger, Cladosporium cladosporioides, and Phytophthora sp. A. niger was significantly inhibited by β-sitosterol, 20
(29)-lupene-3β-isoferulate and shinanolone at 0.01mgml−1. Of all the compounds tested, only octahydroeuclein was found to be significantly effective
against Phytophthora sp. at 0.1 mg ml−1. β-Sitosterol and octahydroeuclein inhibited the growth of C. cladosporioides significantly at 0.01 mg ml−1.
None of the isolated compounds exhibited significant activity against A. flavus at 0.01 mg ml−1.
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Fungal pathogens are capable of causing serious diseases in
humans and animals (Van Burik and Magee, 2001). Fungal
infections are commonly seen in patients suffering from AIDS.
(Kwong-Chung and Bennett, 1992). Aspergillosis caused by
Aspergillus species is a rare complication of AIDS and usually
seen in patients with advanced disease (Ioachim, 1989). Serious
ailments such as Phaeohyphomycosis, pneumonia, necrotising
enterocolitis, are caused by fungi like Cladosporium clados-
porioides, Phytophthora sp. (Hallstrom et al., 2004; Vieira et
al., 2001). Due to problems with the toxicity of existing
antifungal agents as well as the emergence of drug-resistant
strains, the use of plants can be exploited as an alternative way
to control these pathogens. Many plants contain secondary
compounds that have been found to have an inhibitory effect on
harmful bacterial and fungal human pathogens (Lall and Meyer,
2000; Magama et al., 2002; Masika and Afolayan, 2002; Meyer
and Afolayan, 1995).
Euclea natalensis A. DC. belonging to the family Ebena-
ceae, is widely distributed in tropical, subtropical Africa and is⁎ Corresponding author.
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doi:10.1016/j.sajb.2006.03.005common on the East Coast of South Africa. The roots of this
plant are being used for curing bronchitis, pleurisy, chronic
asthma and urinary tract infections by the Zulus. The roots are
also used as a dye, for skin infections caused byMycobacterium
leprae and to relieve headache and toothache by the local
inhabitants of South Africa (Palgrave and Drummond, 1977).
According to previous investigations, roots of E. natalensis
have been found to be antibacterial against Mycobacterium
tuberculosis and a number of Gram-positive and Gram-negative
bacterial species (Lall and Meyer, 1999, 2000; Khan et al.,
1978). The aim of the current study was to investigate the ac-
tivity of the purified compounds from the root bark of E.
natalensis against various fungal species. This is the first report
on the inhibitory effect of compounds isolated from Euclea
natalensis root extracts against fungal pathogens.
2. Material and methods
2.1. Plant material
Roots of E. natalensis were collected from Mputaland, a
region in the KwaZulu–Natal province of South Africa. A
voucher specimen (N.L. 22) was identified and deposited at the
H.G.W.J. Schweickerdt Herbarium (PRU), Pretoria.ts reserved.
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Four fungal species, Aspergillus flavus, Aspergillus niger,
C. cladosporioides, and Phytophthora sp. used in this study
were obtained from the Department of Microbiology and Plant
Pathology, University of Pretoria. All strains were maintained
on potato dextrose agar (PDA) at ±25 °C.
2.3. Isolation of compounds
Four triterpenoids namely lupeol, betulin, 20(29)-lupene-3β-
isoferulate, β-sitosterol and two naphthoquinones, octahy-
droeuclein and shinanolone (Fig. 1a–f) were isolated and puri-
fied from the root bark of E. natalensis, as mentioned in our
previous paper (Weigenand et al., 2004). The chemical struc-
tures of the compounds were determined by spectroscopic
methods (1H and 13C NMR) and comparison with authentic
samples. A stock solution (10 mg ml−1) of each compound was
prepared in acetone and stored at 4 °C until further analysis.
2.4. Antifungal bioassay
For the antifungal assay, the required amount of compounds
were added to sterile PDA in 65 mm Petri dishes before
congealing to yield final concentrations of 0.1, 0.05 andFig. 1. Compounds isolated from the root bard of Euclea natalensis: (a) lupeol, (b
(f) octahydroeuclein.0.01 mg ml−1. Three blank plates containing PDA-agar and 2%
acetone served as controls. Bifonazole (Srbolek, Belgrade) and
metalaxyl (Sungbo Chemical Co, Korea) were used as positive
drug control. Once the agar had solidified, a 5 mm plug of a 7-
day-old fungal culture was placed in the centre of the Petri
dishes containing the compound-amended and acetone-
amended PDA plates. The plates were sealed with Parafilm
and placed in an incubator at 25 °C. Fungal growth was mea-
sured on two preset diametral lines after 2, 3, and 4 days of
growth. Each treatment was analysed in triplicate. The results of
the 4-day growth was statistically analysed using two-way
analysis of variance (ANOVA) and least significant differences
(P=0.05) were determined according to Student's t test.
3. Results and discussion
A. niger was significantly inhibited by β-sitosterol, 20(29)-
lupene-3β-isoferulate and shinanolone at 0.01mgml−1. Of all the
compounds tested, only octahydroeuclein was found to be
significantly effective against Phytophthora sp. at 0.1 mg ml−1.
β-Sitosterol and the naphthoquinone, octahydroeuclein inhibited
the growth of C. cladosporioides significantly at 0.01 mg ml−1,
similar to the findings of other researchers where a novel
naphthoquinone, ‘Eleutherinone’, was found to have strong activ-
ity in the direct bioautographic assay with the phytopathogenic) betulin, (c) 20(29)-Lupene-3β-isoferulate, (d) β-Sitosterol, (e) shinanolone,
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naphthoquinone-2-yl and naphthoquinone derivatives 6–9 and
2,3-disubstituted 1,4-naphthoquinones were also found to be
antifungal (Tandon et al., 2004). Bifonazole, a positive drug
control, inhibited the growth of A. niger, A. flavus and C.
cladosporioides at 15 μg/ml whereas ‘metalaxyl’ inhibited the
growth of Phytophthora sp. at 30 μg/ml.Fig. 2. Antifungal activity of (a) lupeol, (b) betulin, (c) 20(29)-lupene-3β-isoferu
pathogens. ⁎Each value of a bar is a mean of three replicates. Values of the bars with
(P=0.05) according to the Student's t-test.β-Sitosterol was found to have good inhibitory activity against
all the tested fungi in this study except against A. flavus. The
antifungal activity of β-sitosterol isolated from Dioscorea alata
has been shown as inhibitor of the elongation of germ tubes of
Fusarium molniliforme as high as 82% at 50 mg ml−1. The
findings of the present study are in confirmation with antifungal
activity of β-sitosterol from Senecio lyratus in in vitrolate, (d) β-sitosterol, (e) shinanolone, (f) octahydroeuclein on selected fungal
in each fungal species not followed by the same letter are significantly different
Fig. 2 (continued).
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activity of β-sitosterol isolated from Artemisia sp. was
observed (Tang et al., 2000). None of the isolated compounds
exhibited significant activity against A. flavus at 0.01 mg ml−1
(Fig. 2a–f).
Crude extract and semi purified fractions obtained from Eu-
clea crispa have been found to have inhibitory effect on human
pathogenic fungi (Magama et al., 2002). The results of this work
suggested that the suppression of fungi growth supports the use of
root bark of E. natalensis for different types of infections byindigenous people of South Africa. The results show a fairly high
correlation between antifungal activity of E. natalensis root bark
and the traditional medicinal use by tribes of Southern Africa.
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